April 2017 in “Al-Azhar Medical Journal” In this study conducted at Al-Azhar University Hospital, 60% of patients with localized alopecia areata responded to treatment with autologous platelet-rich plasma, with 89% of responders showing substantial improvement, suggesting PRP as an effective treatment option for this condition.
PRP works well with other treatments for better skin, hair, and scar results.
4 citations
,
March 2008 in “Hair transplant forum international” This abstract provides an overview of the importance of using reliable and valid information for evidence-based medicine, without presenting new experimental results.
April 2024 in “European Journal of Dermatology” This study suggests that the PPP2R3C gene may confer susceptibility to psoriatic arthritis and psoriasis vulgaris in Chinese patients, with additional possible associations involving IL-23R, ERN1, IFIH1, and KIF3A genes.
In this observational and interventional study conducted in Dhaka, Bangladesh, PRP treatment led to clinical improvements in hair count, thickness, and density among 20 out of 30 male patients with androgenetic alopecia, with significant statistical support (p-value 0.00) following 2-3 treatment sessions.
1 citations
,
January 2021 in “Indian Dermatology Online Journal” This expert group provided recommendations for preparing and using platelet-rich plasma in treating androgenetic alopecia, suggesting a manual double-spin method and specific dosing, although further studies on injectable platelet-rich fibrin are needed.
April 2025 in “Russian Pediatric Journal” This review discusses the application of PRP therapy in pediatric settings and highlights the current lack of sufficient data for its widespread clinical use.
April 2016 in “Dermatología Revista Mexicana” This experimental study found no significant difference in hair follicle characteristics after short-term treatment with autologous platelet-rich plasma in individuals with androgenic alopecia compared to placebo.
April 2021 in “Journal of Investigative Dermatology” This study explored the use of an AI-driven device, HairMetrix, to quantitatively assess the effects of PRP treatments on scalp health in two Caucasian women with androgenetic alopecia, reporting increases in average hair width and follicle count after one treatment.
4 citations
,
January 2023 in “bioRxiv (Cold Spring Harbor Laboratory)” This study identified the genes for pyochelin siderophore biosynthesis as a novel target regulated by the heme-responsive PrrH sRNA in Pseudomonas aeruginosa.
2 citations
,
January 2020 in “Libri Oncologici Croatian Journal of Oncology” In this study, PRP injections into the muscular layer of rabbits' intestinal walls improved anastomosis regeneration with less adhesion compared to PRP soaking, though further research is needed to determine the best application method.
1 citations
,
September 2018 in “Plastic and reconstructive surgery. Global open” This study found that a single session of nanofat combined with platelet-rich plasma significantly increased hair density and thickness in male androgenic alopecia patients compared to platelet-rich plasma alone, with effects partially persisting at 12 months.
December 2024 in “eCommons - AKU (Aga Khan University)” This study concluded that the platelet rich plasma injectable competency assessment tool (PICAT) demonstrated strong validity, internal consistency, and inter-rater reliability for evaluating dermatology residents at PNS Shifa Hospital.
December 2022 in “Journal of Clinical Medicine” This study reported that a new PRP application protocol with two treatments enhanced hair growth metrics in the vertex region of androgenetic alopecia patients within six months.
June 2025 in “Dermatologic Surgery” This study found that growth factor concentrate provides quicker improvements for patterned hair loss, but platelet-rich plasma offers more sustained benefits after treatment.
April 2017 in “Plastic surgical nursing” Platelet-rich plasma (PRP) is an effective treatment for hair loss that involves scalp injections and requires ongoing maintenance.
September 2023 in “Journal of the American Academy of Dermatology” This review discusses the potential of platelet-rich plasma for treating scarring alopecias and reports no clinical results; the authors emphasize the need for further research.
183 citations
,
January 2014 in “BioMed Research International” This study reported that AA-PRP injections significantly increased hair count and density in individuals with pattern hair loss compared to baseline, demonstrating their potential for enhancing hair growth.
2 citations
,
April 2022 in “Der Hautarzt” This review discusses the current literature on platelet rich plasma injections for androgenetic alopecia, noting that while some studies report positive outcomes, they often suffer from methodological weaknesses and inconsistent results.
24 citations
,
January 2018 in “Journal of Visualized Experiments” In this study, 23 patients with androgenetic alopecia were treated with non-activated autologous platelet-rich plasma (A-PRP) administered through interfollicular injections, but the abstract provides no results of the treatment's effectiveness.
3 citations
,
November 2016 in “Journal of Pakistan Association of Dermatology” This study found that autologous platelet rich plasma (PRP) may be a safe and effective treatment for limited alopecia areata, with varying levels of hair regrowth observed among patients.
May 2020 in “Journal of the Dermatology Nurses’ Association” This study concluded that using a multimedia patient education tool may improve patient comprehension of platelet-rich plasma treatment for androgenetic alopecia in a dermatology practice.
July 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review discusses the process and benefits of Platelet-Rich Plasma therapy for hair restoration, emphasizing its safety and potential for encouraging hair growth, but reports no new clinical results.
April 2023 in “Australasian Journal of Dermatology” Both methods of platelet-rich plasma showed positive effects on hair loss.
34 citations
,
January 2022 in “Human Reproduction Open” This study found no clinically significant effects of intraovarian injection of platelet-rich plasma on ovarian function over one year in patients with extremely low functional ovarian reserve.
December 2023 in “PubMed” This study found that both single- and double-spin PRP preparation methods significantly increased thrombocyte counts and improved hair parameters in males with androgenetic alopecia, with the single-spin method showing a more significant increase in thrombocyte count.
March 2026 in “Journal of Cosmetic Dermatology” This review discusses platelet-rich plasma therapy for androgenic alopecia and reports no clinical results; the authors emphasize the need for standardized protocols and large-scale studies to confirm its long-term efficacy.
March 2026 in “Journal of Ovarian Research” This review explores the potential of platelet-rich plasma therapy for early ovarian reserve decline and premature ovarian insufficiency, indicating some ovarian function improvements in initial studies but highlighting the need for further research.
40 citations
,
March 2018 in “Aesthetic Surgery Journal” This study found that a single injection of platelet-rich stroma significantly increased hair density in men with androgenetic alopecia within 6 to 12 weeks, with no reported side effects.
December 2024 in “Anti-Aging Eastern Europe” This study highlights the potential of Platelet-Rich Plasma (PRP) as an effective treatment for improving skin texture, tone, and elasticity, and treating hair loss, warranting further research to optimize its use in aesthetic dermatology.